Alexza Pharmaceuticals Inc (NASDAQ:ALXA)
CAPS Rating:
An emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions.
RSS Headlines
Fool UK
Recs
Upcoming catalysts that will provide a high run up before pdufa. Between the upcoming rally, the potential of az-004, and their drug delivery technology this can be a multi-bagger by the end of the year and in the long term/